Considering that phosphorylation levels of PPARγ Ser245 are regulated by various ligands, the reduced ligand binding from the PPARγ helix H3 mutations including Q286E might increase the phosphorylation level of PPARγ Ser245, resulting in cancer cell survival through the dysregulation of p53 signaling. Here, PPARG is linked to cancer.